Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa
  • Amsterdam
  • Berlin
  • Brussels
  • Copenhagen
  • Danske Bank
  • Denmark
  • DFDS
  • DSV
  • Faroe Islands
  • Greenland
  • Helsinki
  • LEGO
  • Mærsk
  • Novo Nordisk
  • Ørsted
  • Oslo
  • Riga
  • Stockholm
  • Tallinn
  • Vestas Wind Systems
  • Vilnius
  • Warsaw
Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa

Browsing Tag

Nordisk

253 posts
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-08-24
Bagsværd, Denmark, 24 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in…
NNovo Nordisk
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851
Read More

Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851

  • 2026-08-24
LX9851 is a first-in-class, oral non-incretin candidate being developed by Novo Nordisk for the treatment of obesity and…
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-08-17
Bagsværd, Denmark, 17 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in…
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-08-10
Bagsværd, Denmark, 10 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance…
NNovo Nordisk
Novo Nordisk's Defining Moment: Can a Pill Outweigh a Pipeline Setback?
Read More

Novo Nordisk’s Defining Moment: Can a Pill Outweigh a Pipeline Setback?

  • 2026-08-04
The arithmetic of Novo Nordisk’s share price has become uncomfortably simple. At Monday’s close of 40.83 euros, the…
NNovo Nordisk
Novo Nordisk Faces a Legal Double Header as Earnings Approach
Read More

Novo Nordisk Faces a Legal Double Header as Earnings Approach

  • 2026-07-30
The Danish pharmaceutical heavyweight is fighting on two legal fronts just days before a pivotal earnings report, with…
NNovo Nordisk
Novo Nordisk: A Stock Caught Between Courtroom Battles and a Deep Value Gap
Read More

Novo Nordisk: A Stock Caught Between Courtroom Battles and a Deep Value Gap

  • 2026-07-29
Novo Nordisk’s shares have staged a remarkable recovery from their March lows, yet the Danish pharmaceutical giant remains…
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Novo Nordisk A/S – share repurchase programme

  • 2026-07-27
Bagsværd, Denmark, 27 July 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in…
NNovo Nordisk
Novo Nordisk Deploys Licensed Semaglutide Copy in South Africa While Waging Legal War on Two Fronts
Read More

Novo Nordisk Deploys Licensed Semaglutide Copy in South Africa While Waging Legal War on Two Fronts

  • 2026-07-27
The Danish drugmaker is fighting for its GLP-1 franchise on multiple fronts — from the courtroom to the…
NNovo Nordisk
Novo Nordisk Faces a Two-Pronged Test: Quarterly Results and a Pivotal FDA Decision
Read More

Novo Nordisk Faces a Two-Pronged Test: Quarterly Results and a Pivotal FDA Decision

  • 2026-07-26
The Danish pharmaceutical giant Novo Nordisk enters a defining stretch this week, with its second-quarter earnings due on…
NNovo Nordisk
Novo Nordisk Takes Lilly to Court Over GLP-1 Ad Claims as Market Share Battle Intensifies
Read More

Novo Nordisk Takes Lilly to Court Over GLP-1 Ad Claims as Market Share Battle Intensifies

  • 2026-07-26
Novo Nordisk has escalated its legal confrontation with Eli Lilly, filing for a preliminary injunction in a New…
NNovo Nordisk
Novo Nordisk Faces a Double Squeeze: Lilly’s Record-Breaking Data and a High-Stakes Court Date
Read More

Novo Nordisk Faces a Double Squeeze: Lilly’s Record-Breaking Data and a High-Stakes Court Date

  • 2026-07-25
Eli Lilly has thrown down a fresh gauntlet in the GLP-1 arms race, unveiling late-stage data that shows…
Denmark
www.europesays.com